Article Information
History
- November 24, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Hannelore Neuhauser1,#,*,
- Angelika Schaffrath Rosario1,#,
- Hans Butschalowsky1,
- Sebastian Haller1,
- Jens Hoebel1,
- Janine Michel1,
- Andreas Nitsche1,
- Christina Poethko-Müller1,
- Franziska Prütz1,
- Martin Schlaud1,
- Hans W. Steinhauer2,
- Hendrik Wilking1,
- Lothar H. Wieler1,
- Lars Schaade1,
- Stefan Liebig2,3,
- Antje Gößwald1,##,
- Markus M. Grabka2,##,
- Sabine Zinn2,4,## and
- Thomas Ziese1,##
- 1Robert Koch Institute, Berlin, Germany
- 2Socio-Economic Panel, German Institute for Economic Research, Berlin, Germany
- 3SOEP & Department of Political and Social Sciences, Free University, Berlin, Germany
- 4SOEP & Department of Social Sciences, Humboldt University, Berlin, Germany
- ↵*Corresponding author Correspondence: Hannelore Neuhauser, MD, PHD, MPH, Robert Koch Institute, Department of Epidemiology and Health Monitoring, General-Pape-Str. 62–66, 12101 Berlin, Germany, Phone: +49 (0) 30 18754 3462, Email: neuhauserh{at}rki.de
↵#; ## These authors contributed equally
Posted November 24, 2021.
Germany’s low SARS-CoV-2 seroprevalence confirms effective containment in 2020: Results of the nationwide RKI-SOEP study
